162 related articles for article (PubMed ID: 8391242)
1. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
Mørkve O; Halvorsen OJ; Skjaerven R; Stangeland L; Gulsvik A; Laerum OD
Anticancer Res; 1993; 13(3):571-8. PubMed ID: 8391242
[TBL] [Abstract][Full Text] [Related]
2. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
3. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
Ebina M; Steinberg SM; Mulshine JL; Linnoila RI
Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
[TBL] [Abstract][Full Text] [Related]
5. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
7. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
8. p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis.
Pappot H; Francis D; Brünner N; Grondahl-Hansen J; Osterlind K
Clin Cancer Res; 1996 Jan; 2(1):155-60. PubMed ID: 9816102
[TBL] [Abstract][Full Text] [Related]
9. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
Bozcuk H; Gumus A; Ozbilim G; Sarper A; Kucukosmanoglu I; Ozbudak IH; Artac M; Ozdogan M; Samur M; Kaya A; Savas B
Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726
[TBL] [Abstract][Full Text] [Related]
10. [Studies on flow cytometric analysis of nuclear DNA content in non-small cell lung cancer].
Isobe H
Hokkaido Igaku Zasshi; 1991 Jan; 66(1):49-58. PubMed ID: 1848524
[TBL] [Abstract][Full Text] [Related]
11. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
Zhang Z; Ma J; Li N; Sun N; Wang C
Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
[TBL] [Abstract][Full Text] [Related]
12. [The prognostic significance of nuclear DNA content in non-small-cell lung carcinoma].
Yamaoka N; Uchiyama Y; Kimino K; Akamine S; Matsuo S; Tsuji K
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1608-16. PubMed ID: 2175839
[TBL] [Abstract][Full Text] [Related]
13. Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients.
Harpole DH; Marks JR; Richards WG; Herndon JE; Sugarbaker DJ
Clin Cancer Res; 1995 Jun; 1(6):659-64. PubMed ID: 9816029
[TBL] [Abstract][Full Text] [Related]
14. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients.
Ichinose Y; Hara N; Ohta M; Yano T; Maeda K; Asoh H; Katsuda Y
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):90-4. PubMed ID: 8391613
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of immunohistochemically detected p53 protein expression in non-small cell lung cancer treated with radiation therapy.
Hayakawa K; Mitsuhashi N; Hasegawa M; Saito Y; Sakurai H; Ohno T; Maebayashi K; Ebara T; Hayakawa KY; Niibe H
Anticancer Res; 1998; 18(5B):3685-8. PubMed ID: 9854477
[TBL] [Abstract][Full Text] [Related]
16. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of flow cytometry in non-small-cell lung cancer.
Rice TW; Bauer TW; Gephardt GN; Medendorp SV; McLain DA; Kirby TJ
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):210-7. PubMed ID: 8393505
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53 and ras p21 protein expression in surgically treated non-small cell lung carcinoma.
Cohen R; Guber A; Koren R; Marom Z; Siegal A
Rom J Morphol Embryol; 1998; 44(1-4):117-23. PubMed ID: 15678852
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in non small cell lung cancer: clinical and biological correlations.
Fontanini G; Bigini D; Vignati S; Macchiarini P; Pepe S; Angeletti CA; Pingitore R; Squartini F
Anticancer Res; 1993; 13(3):737-42. PubMed ID: 8100413
[TBL] [Abstract][Full Text] [Related]
20. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
Bellotti M; Elsner B; Paez De Lima A; Esteva H; Marchevsky AM
Mod Pathol; 1997 Dec; 10(12):1221-7. PubMed ID: 9436967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
